Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postpartum depression after cesarean delivery
ChiCTR2100045498Phase 4Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Edinburgh Postnatal Depression Scale. Started Jan 2020; status: completed.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2100045498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045498.